Richard J. Meadows

Richard J. Meadows serves as a procurement professional responsible for managing complex acquisitions within the biomedical and diagnostic services sector. Though his official title and agency are not specified, his contracting patterns reveal a focused role in securing critical medical technologies and laboratory services essential to public health infrastructure. He routinely handles competitive procurements under FAR Part 15, emphasizing technical evaluation and performance-based requirements for high-precision medical equipment and diagnostic solutions. His work supports mission-critical functions involving clinical diagnostics, medical device procurement, and healthcare delivery systems. Meadows maintains a broad vendor ecosystem, engaging with manufacturers of in-vitro diagnostic substances, surgical instruments, and diagnostic imaging centers, as well as specialized service providers in medical laboratory operations. His procurement approach prioritizes technical capability and regulatory compliance, often requiring vendors to hold FDA clearances, ISO certifications, or CLIA accreditation. While no single contractor dominates his portfolio, he consistently collaborates with both large-scale medical technology firms and niche suppliers capable of meeting stringent performance and quality standards. His set-aside preferences reflect a balanced commitment to small business participation, with 12% of awards designated for total small business set-asides under FAR 19.5 and an additional 4% allocated to 8(a) and service-disabled veteran-owned small business programs. This demonstrates a deliberate effort to broaden supplier diversity while maintaining competitive integrity. The majority of his acquisitions—84%—remain open to all competitors, indicating a preference for market-wide competition unless socioeconomic goals justify targeted set-asides. Meadows’ primary industry focus centers on NAICS 325413 (in-vitro diagnostic manufacturing) and 339112 (surgical and medical instrument manufacturing), with significant activity in diagnostic imaging centers and medical laboratories. His expertise lies in procuring precision diagnostic tools, analytical instrumentation, and laboratory support services that underpin clinical decision-making and public health surveillance. He operates at the intersection of regulatory compliance, clinical utility, and supply chain resilience in the biomedical procurement domain.